Sommer, A., Hermawan, A., Mickler, F. M., Ljepoja, B., Knyazev, P., Bräuchle, C., . . . Roidl, A. (2016). Salinomycin co-treatment enhances tamoxifen cytotoxicity in luminal A breast tumor cells by facilitating lysosomal degradation of receptor tyrosine kinases. Oncotarget.

Sommer, Ann-Katrin, Adam Hermawan, Frauke Martina Mickler, Bojan Ljepoja, Pjotr Knyazev, Christoph Bräuchle, Axel Ullrich, Ernst Wagner, and Andreas Roidl. "Salinomycin Co-treatment Enhances Tamoxifen Cytotoxicity in Luminal A Breast Tumor Cells By Facilitating Lysosomal Degradation of Receptor Tyrosine Kinases." Oncotarget 2016.

Sommer, Ann-Katrin, et al. "Salinomycin Co-treatment Enhances Tamoxifen Cytotoxicity in Luminal A Breast Tumor Cells By Facilitating Lysosomal Degradation of Receptor Tyrosine Kinases." Oncotarget 2016.